ISRVF:OTC-iShares Public Limited Company - iShares MSCI Japan USD Hedged UCITS ETF (Acc) (USD)

ETF | Others |

Last Closing

USD 75.97

Change

-0.27 (-0.36)%

Market Cap

N/A

Volume

313.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-12 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
CSTNL iShares VII Public Limited Com..

-2.16 (-0.34%)

USD 32.85B
ZKBGF ZKB Gold ETF

N/A

USD 8.96B
TOETF Tosei Corporation

N/A

USD 7.70B
EFMSF ETFS Metal Securities Limited ..

N/A

USD 7.39B
EBCRY EBCRY

N/A

USD 4.61B
ETHE Grayscale Ethereum Trust (ETH)

+0.69 (+3.18%)

USD 3.43B
SSEEF SSgA SPDR ETFs Europe I Public..

-0.23 (-0.31%)

USD 2.95B
ZKBHF ZKB Gold ETF

N/A

USD 2.93B
GDRPF Golden Resources Development I..

N/A

USD 2.70B
ISRPF iShares Public Limited Company..

-0.50 (-0.50%)

USD 2.22B

ETFs Containing ISRVF

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.36% 21% F 38% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.36% 21% F 38% F
Trailing 12 Months  
Capital Gain 11.03% 53% F 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.03% 50% F 61% D-
Trailing 5 Years  
Capital Gain 97.07% 89% A- 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 97.07% 88% B+ 83% B
Average Annual (5 Year Horizon)  
Capital Gain 20.12% 83% B 64% D
Dividend Return 20.12% 83% B 61% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 15.95% 53% F 92% A
Risk Adjusted Return 126.19% 100% F 99% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike